Zacks Investment Research on MSN

Axsome Therapeutics begins Phase III study on AXS-14 for fibromyalgia

Axsome Therapeutics AXSM announced the initiation of the phase III study called FORWARD with the dosing of the first patient, ...

Axsome begins Phase III AXS-14 FORWARD trial for fibromyalgia management

The study consists of an open-label AXS-14 treatment period followed by a randomised, double-blind treatment period.
Tennessean

Narrated Fibromyalgia Study Results Now Available

CARLSBAD, CA, UNITED STATES, December 31, 2025 /EINPresswire.com/ — AVACEN Medical announced today that Dr. Francisco Cidral, ND, PhD’s narrated review of the ...
Medical Xpress

Overactive bladder prevalent among women with fibromyalgia, study finds

Overactive bladder (OAB) is prevalent among women with fibromyalgia (FM) and is associated with higher symptom severity and comorbidity, according to a study published in Neurourology Urodynamics.
High Times

Fibromyalgia Patients Find Relief From Oral THC Treatment, Study Shows

Patients suffering from a condition characterized by pain and fatigue could find relief in the form of oral THC treatment, according to newly published research. The study, published in the German ...
News Medical

Study: Traditional CBT as effective as exposure therapy for fibromyalgia

There does not appear to be any profound differences between so-called exposure-based CBT and traditional CBT in the treatment of fibromyalgia, according to a study led by researchers at Karolinska ...